We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Bayer Sues Watson Over Generic Yaz Application
Bayer Sues Watson Over Generic Yaz Application
November 13, 2007
In response to Watson Pharmaceuticals submitting an abbreviated new drug application (ANDA) for a generic version of Yaz, Bayer HealthCare Pharmaceuticals sued the company for patent infringement in the U.S. District Court for the District of Nevada.